Stryker Corporation

NYSE:SYK Stock Report

Market Cap: US$141.1b

Stryker Future Growth

Future criteria checks 3/6

Stryker is forecast to grow earnings and revenue by 17.3% and 7.7% per annum respectively. EPS is expected to grow by 17.2% per annum. Return on equity is forecast to be 23.8% in 3 years.

Key information

17.3%

Earnings growth rate

17.22%

EPS growth rate

Medical Equipment earnings growth13.6%
Revenue growth rate7.7%
Future return on equity23.84%
Analyst coverage

Good

Last updated31 Oct 2025

Recent future growth updates

Recent updates

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

Sep 08
Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

Stryker: Strong Multi-Faceted Growth Continuing To Support The Shares

Aug 19

Investors Can Find Comfort In Stryker's (NYSE:SYK) Earnings Quality

Aug 08
Investors Can Find Comfort In Stryker's (NYSE:SYK) Earnings Quality

Estimating The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jul 09
Estimating The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

With Stryker Corporation (NYSE:SYK) It Looks Like You'll Get What You Pay For

Jun 16
With Stryker Corporation (NYSE:SYK) It Looks Like You'll Get What You Pay For

Increases to CEO Compensation Might Be Put On Hold For Now at Stryker Corporation (NYSE:SYK)

May 02
Increases to CEO Compensation Might Be Put On Hold For Now at Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Has A Rock Solid Balance Sheet

May 01
Stryker (NYSE:SYK) Has A Rock Solid Balance Sheet

Calculating The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Apr 07
Calculating The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker Corporation's (NYSE:SYK) Share Price Matching Investor Opinion

Mar 16
Stryker Corporation's (NYSE:SYK) Share Price Matching Investor Opinion

Is Stryker Corporation (NYSE:SYK) Potentially Undervalued?

Feb 26
Is Stryker Corporation (NYSE:SYK) Potentially Undervalued?

There May Be Some Bright Spots In Stryker's (NYSE:SYK) Earnings

Feb 05
There May Be Some Bright Spots In Stryker's (NYSE:SYK) Earnings

Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?

Jan 27

Here's Why We Think Stryker (NYSE:SYK) Is Well Worth Watching

Jan 17
Here's Why We Think Stryker (NYSE:SYK) Is Well Worth Watching

Stryker: Starting 2025 With A Bolt-On Deal For Inari Medical

Jan 08

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Dec 26
We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation: A Wide-Moat Medical Device Company, But Overvalued

Dec 24

Stryker (NYSE:SYK) Is Paying Out A Larger Dividend Than Last Year

Dec 13
Stryker (NYSE:SYK) Is Paying Out A Larger Dividend Than Last Year

Investor Optimism Abounds Stryker Corporation (NYSE:SYK) But Growth Is Lacking

Dec 03
Investor Optimism Abounds Stryker Corporation (NYSE:SYK) But Growth Is Lacking

At US$386, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Nov 21
At US$386, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Oct 16

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Earnings and Revenue Growth Forecasts

NYSE:SYK - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202729,4265,1145,3276,07120
12/31/202627,1654,5654,4585,38627
12/31/202525,0353,8683,7404,44826
9/30/202524,3812,9434,0734,832N/A
6/30/202523,8182,9184,0244,766N/A
3/31/202523,2182,8593,5774,288N/A
12/31/202422,5952,9933,4874,242N/A
9/30/202421,9743,5903,2053,839N/A
6/30/202421,3893,4482,8033,415N/A
3/31/202420,9633,3612,8583,470N/A
12/31/202320,4983,1653,1363,711N/A
9/30/202319,8852,5852,5683,186N/A
6/30/202319,4552,7092,4173,025N/A
3/31/202318,9522,6272,2672,866N/A
12/31/202218,4492,3582,0362,624N/A
9/30/202217,9482,4572,0152,621N/A
6/30/202217,6292,0792,0672,665N/A
3/31/202217,4302,0152,4533,014N/A
12/31/202117,1081,9942,7383,263N/A
9/30/202116,6691,9003,0163,500N/A
6/30/202116,2462,0832,9733,396N/A
3/31/202114,7161,4082,7123,138N/A
12/31/202014,3511,5992,7903,277N/A
9/30/202014,2201,7562,2542,775N/A
6/30/202014,0701,6011,9602,575N/A
3/31/202014,9562,1641,7982,469N/A
12/31/201914,8842,0831,5422,191N/A
9/30/201914,5493,4261,8982,502N/A
6/30/201914,2043,550N/A2,491N/A
3/31/201913,8763,522N/A2,626N/A
12/31/201813,6013,553N/A2,610N/A
9/30/201813,2761,236N/A2,243N/A
6/30/201813,0401,080N/A1,704N/A
3/31/201812,7301,019N/A1,705N/A
12/31/201712,4441,020N/A1,559N/A
9/30/201712,1301,779N/A1,538N/A
6/30/201711,9571,700N/A1,961N/A
3/31/201711,7851,689N/A1,804N/A
12/31/201611,3251,647N/A1,915N/A
9/30/201610,8831,659N/A1,928N/A
6/30/201610,4701,605N/A917N/A
3/31/201610,0621,617N/A781N/A
12/31/20159,9461,439N/A981N/A
9/30/20159,8491,177N/A907N/A
6/30/20159,818933N/A1,940N/A
3/31/20159,749669N/A1,953N/A
12/31/20149,675515N/A1,782N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SYK's forecast earnings growth (17.3% per year) is above the savings rate (3.1%).

Earnings vs Market: SYK's earnings (17.3% per year) are forecast to grow faster than the US market (15.9% per year).

High Growth Earnings: SYK's earnings are forecast to grow, but not significantly.

Revenue vs Market: SYK's revenue (7.7% per year) is forecast to grow slower than the US market (10.4% per year).

High Growth Revenue: SYK's revenue (7.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SYK's Return on Equity is forecast to be high in 3 years time (23.8%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/31 10:23
End of Day Share Price 2025/10/31 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Stryker Corporation is covered by 59 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Jeffrey JohnsonBaird
Adam FeinsteinBarclays